The detection of focal liver lesions with contrast-enhanced ultrasound

The detection of focal liver lesions with contrast-enhanced ultrasound - Letucontrast 01

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32981

Enrollment

160

Registered

2009-08-14

Start date

2009-08-18

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver tumours

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients >18 years old, with at least one focal liver lesion identified but not completely characterized.

Exclusion criteria

Exclusion criteria: Patients who are critically ill or medically unstable, with previous hypersensitivity to contrast for ultrasound or MRI, left to right cardiac shunts, severe pulmonary hypertension, chronic obstructive pulmonary disease, unstable angina or dysrhythmias, and pregnant or nursing mothers.

Design outcomes

Primary

Measure	Time frame
To compare diagnostic efficacy of contrast-enhanced sonography to MRI in patients with focal liver lesions. The diagnostic criterion will be the ability to diagnose benign versus malignant focal liver lesions. Our overall aim is that CEUS will be incorporated as a diagnostic tool in protocol (-s) for focal liver lesions and in screening algorithms for metastatic liver disease. Both the time to diagnosis and costs per patient are expected to decrease.	—

Measure

Time frame

To compare diagnostic efficacy of contrast-enhanced sonography to MRI in patients with focal liver lesions. The diagnostic criterion will be the ability to diagnose benign versus malignant focal liver lesions. Our overall aim is that CEUS will be incorporated as a diagnostic tool in protocol (-s) for focal liver lesions and in screening algorithms for metastatic liver disease. Both the time to diagnosis and costs per patient are expected to decrease.

—

Secondary

Measure	Time frame
To perform a cost-effectiveness study.	—

Countries

Netherlands

Outcome results